NEW YORK (GenomeWeb) – Immucor announced Monday that it has received final local coverage determinations for its PreciseType HEA test from Medicare Administrative Contractors (MACs) participating in Palmetto's Molecular Diagnostic Services (MolDX) program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.